314 related articles for article (PubMed ID: 25181010)
1. The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
Uehara T; Pogribny IP; Rusyn I
Curr Protoc Pharmacol; 2014 Sep; 66():14.30.1-14.30.10. PubMed ID: 25181010
[TBL] [Abstract][Full Text] [Related]
2. The DEN and CCl
Uehara T; Pogribny IP; Rusyn I
Curr Protoc; 2021 Aug; 1(8):e211. PubMed ID: 34370903
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of DEN and CCl
Zhang Q; Liu Y; Ren L; Li J; Lin W; Lou L; Wang M; Li C; Jiang Y
Sci Rep; 2024 Apr; 14(1):8013. PubMed ID: 38580754
[TBL] [Abstract][Full Text] [Related]
4. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
[TBL] [Abstract][Full Text] [Related]
5. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.
Lin YH; Zhang S; Zhu M; Lu T; Chen K; Wen Z; Wang S; Xiao G; Luo D; Jia Y; Li L; MacConmara M; Hoshida Y; Singal AG; Yopp A; Wang T; Zhu H
Gastroenterology; 2020 May; 158(6):1698-1712.e14. PubMed ID: 31972235
[TBL] [Abstract][Full Text] [Related]
6. Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice.
Marrone AK; Shpyleva S; Chappell G; Tryndyak V; Uehara T; Tsuchiya M; Beland FA; Rusyn I; Pogribny IP
Mol Carcinog; 2016 May; 55(5):808-17. PubMed ID: 25865624
[TBL] [Abstract][Full Text] [Related]
7. Effects of carbon tetrachloride and azathioprine on diethylnitrosamine and N-2-fluorenylacetamide-induced hyperplastic liver nodule and hepatocellular carcinoma.
Sakata T
Acta Med Okayama; 1984 Dec; 38(6):511-24. PubMed ID: 6524446
[TBL] [Abstract][Full Text] [Related]
8. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
Chappell G; Kutanzi K; Uehara T; Tryndyak V; Hong HH; Hoenerhoff M; Beland FA; Rusyn I; Pogribny IP
Int J Cancer; 2014 Jun; 134(12):2778-88. PubMed ID: 24242335
[TBL] [Abstract][Full Text] [Related]
10. Effect of azathioprine and carbon tetrachloride on induction of hyperplastic liver nodule and hepatocellular carcinoma by diethylnitrosamine and N-2-fluorenylacetamide in rats.
Sakata T; Watanabe A; Takei N; Shiota T; Nakatsukasa H; Fujiwara M; Kobayashi M; Nagashima H
Ann N Y Acad Sci; 1983; 417():288-93. PubMed ID: 6142675
[TBL] [Abstract][Full Text] [Related]
11. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.
Romualdo GR; Prata GB; da Silva TC; Fernandes AAH; Moreno FS; Cogliati B; Barbisan LF
PLoS One; 2018; 13(9):e0203879. PubMed ID: 30212575
[TBL] [Abstract][Full Text] [Related]
13. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
[TBL] [Abstract][Full Text] [Related]
14. A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.
Memon A; Pyao Y; Jung Y; Lee JI; Lee WK
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751728
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
Fuchs BC; Hoshida Y; Fujii T; Wei L; Yamada S; Lauwers GY; McGinn CM; DePeralta DK; Chen X; Kuroda T; Lanuti M; Schmitt AD; Gupta S; Crenshaw A; Onofrio R; Taylor B; Winckler W; Bardeesy N; Caravan P; Golub TR; Tanabe KK
Hepatology; 2014 Apr; 59(4):1577-90. PubMed ID: 24677197
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
Uehara T; Ainslie GR; Kutanzi K; Pogribny IP; Muskhelishvili L; Izawa T; Yamate J; Kosyk O; Shymonyak S; Bradford BU; Boorman GA; Bataller R; Rusyn I
Toxicol Sci; 2013 Mar; 132(1):53-63. PubMed ID: 23288052
[TBL] [Abstract][Full Text] [Related]
17. The N-nitrosodiethylamine mouse model: sketching a timeline of evolution of chemically-induced hepatic lesions.
Da Costa RM; Paula-Santos N; Rocha AF; Colaço A; Lopes C; Oliveira PA
Anticancer Res; 2014 Dec; 34(12):7029-37. PubMed ID: 25503129
[TBL] [Abstract][Full Text] [Related]
18. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
[TBL] [Abstract][Full Text] [Related]
19. Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.
Shankaraiah RC; Callegari E; Guerriero P; Rimessi A; Pinton P; Gramantieri L; Silini EM; Sabbioni S; Negrini M
Oncogene; 2019 Nov; 38(45):7035-7045. PubMed ID: 31409896
[TBL] [Abstract][Full Text] [Related]
20. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
Pittala S; Krelin Y; Shoshan-Barmatz V
Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
